Researchers at Stanford have identified amino acid modifications in the IgG Fc region which extend its therapeutic half-life and improve its in vivo receptor binding.
This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.
Different drug delivery agents, including synthetic polymers, virus-based vectors, lipid-based vectors, and extracellular vesicles (EVs), have been explored previously.
Stanford researchers at the Shenoy Lab have tested a method that can detect and predict the outcome of brain machine interface (BMI) tasks using motor cortical brain activity.
Stanford researchers have invented a system for identifying head impacts and rejecting spurious motion events. The system has been implemented in an instrumented mouthguard which measures head kinematics on the sports field.
Researchers in Prof. Mark Schnitzer's laboratory have developed a two-photon scanning microscope for imaging neural activity in a 2x2mm field of view while maintaining a fast scanning rate (~10Hz image update frequency).
Stanford researchers in the WE3 and S3 Labs developed a cloud-based computation and predictive control platform for wastewater treatment facilities energy storage and energy generation. Wastewater treatment is energy and cost intensive.
Stanford researchers have developed a predictive biomarker for hepatocellular carcinoma (HCC) recurrence post-treatment that provides key spatial distribution information about cell interaction.
Stanford researchers have developed a software platform featuring an integrated digital twin framework to enable 24/7, carbon-free operations of electric vehicle (EV) fleets.
Researchers in the Onori Lab have developed a state of charge (SOC) estimation technique for Lithium Iron Phosphate (LFP) batteries using machine learning.
Stanford researchers at the Rao Lab have developed apoptosis imaging probes with an improved new molecular structure enabling high sensitivity and stability with better performance in vivo.
Stanford researchers have developed a new controllable methodology for molecularly targeted ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates.
Researchers in Dr. Michael Lin's lab have developed a fluorescent voltage sensor for non-invasive optical monitoring of electrical events in living cells in vitro and in vivo.
Stanford researchers have developed a novel phantom which can integrate quality assurance (QA) procedures for radiofrequency tracking system, surface mapping system, Winston-Lutz test, the imaging system isocenter test and laser verification.